From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Breast Cancer>
  4. Archives

Breast Cancer: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 76-100 of 264 are shown

Is Computer-Aided Detection Good for Screening Mammography?

CAD seemed to raise mammography recall rate in a U.K. study, but the implications for U.S. practice are unclear.

Is Computer-Aided Detection Good for Screening Mammography?

CAD seemed to raise mammography recall rate in a U.K. study, but the implications for U.S. practice are unclear.

Minimizing Bone Loss Related to Therapy with Aromatase Inhibitors

Denosumab seemed protective against AI-induced bone loss in women with early-stage breast cancer.

Maintaining Bone Mass in Premenopausal Breast Cancer Patients: How Effective Is Zoledronic Acid?

IV bisphosphonate provided long-term protection against BMD loss in premenopausal women receiving adjuvant endocrine therapy.

Prophylactic Mastectomy’s Psychological Aftermath

Swedish investigators found changes in reported sexuality and body image and a substantial drop in anxiety at 1 year after prophylactic mastectomy.

Aromatase Inhibitors and Joint Symptoms: Who Is at Risk?

Risk factors for incident arthralgias included use of an AI, prior hormone therapy or chemotherapy, and hormone-receptor–positive tumors.

Insights from a Negative Result

Not all taxane-containing adjuvant regimens are equivalent, and some node-positive breast cancer patients with low gene-assay–based recurrence scores might do well with endocrine therapy alone.

Recertification Scores Correlate with Quality of Care

Some indicators of quality of care were positively associated with top scores on the internal medicine recertification exam.

LNG IUS Safe for Breast Cancer Patients

Recurrence rates were not significantly higher in women using LNG IUS after treatment for breast cancer than in similar patients who did not use the system.

Do Women Complete Radiation Therapy for Breast Cancer?

Despite high overall rates of completion, some women did not finish their XRT.

Learning More About Lymphedema After Breast Cancer Surgery

Lymphedema occurred more often after breast cancer surgery than was previously thought; physical activity seemed protective.

Pregnancy Worsens Breast Cancer Outcomes

Six-year risk for death was greater when breast cancer was diagnosed during or within 1 year after pregnancy.

Aromatase Inhibitors and Arthralgias

Characterizing the joint pain associated with adjuvant aromatase inhibitors in postmenopausal women with early breast cancer

Management of Depression in Cancer Patients

Nurses provided effective, and cost-effective, depression care.

Screening Mammography: Which Factors Foretell Accuracy?

Some mammography facilities produce more-accurate results than others, but identifying those facilities was not straightforward.

Women with Genetic Predisposition for Breast Cancer Might Benefit from MRI Screening

Adding MRI to mammography detects more cancers in women at high risk.

Lifetime Physical Activity and Risk for Premenopausal Breast Cancer

Women who engaged in regular strenuous exercise during adolescence and young adulthood benefited most.

For Screening Mammography, Is There a "Too Old"?

Study results indicate that mammography should have no upper age limit.

Menopausal Estrogen Therapy and Risk for Benign Proliferative Breast Disease

WHI analysis showed that ET was associated with doubling of risk for BPBD.

Ultrasound, Mammography, or Both for Breast Cancer Detection?

Added to mammography, screening ultrasound improved detection of breast cancers in high-risk women but also generated more false positives.

Ultrasound Plus Mammography for Breast Cancer Screening

Adding ultrasound improved detection but led to more false-positives.

Lapatinib for Treatment of Metastatic Brain Metastases

This antitumor agent failed to provide a predefined CNS response, but its use was associated with volumetric reductions in target lesions.

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

Frequent paclitaxel therapy, but not docetaxel therapy, benefitted women with HER2-positive or HER2-negative tumors.

Pharmacogenomics, CYP2D6, and Adjuvant Endocrine Therapy

CYP2D6 genotype data could help tailor hormonal therapy for postmenopausal breast cancer patients.

More Data on Aromatase Inhibitors for Breast Cancer

Extending endocrine therapy beyond 5 years prevents some breast cancer relapses.

Items 76-100 of 264 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.